总时间（秒）：61.61
问答时间（秒）：59.36

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutants of LRRK2 have been linked to the onset of parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The paper directly states a link between LRRK2 mutations and Parkinson's disease, establishing a disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study assessed tolerance to oxidative stress as a measure of LRRK2 function. Oxidative stress is implicated in Parkinson's disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay (oxidative stress tolerance) is relevant to the disease mechanism, as oxidative stress plays a role in Parkinson's disease, making the assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study used wild-type LRRK2 and mutant LRRK2 (Y1699C and G2019S) to assess tolerance to H2O2-induced oxidative stress in HEK293 and SH-SY5Y cells.",
          "judgment": "Yes",
          "reasoning": "The study included both wild-type and mutant controls, indicating basic controls were present. The experiment was performed using cell lines (HEK293 and SH-SY5Y)."
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type LRRK2 and mutant LRRK2 (Y1699C and G2019S) were used as controls. The study does not explicitly mention replicates but implies multiple experiments were conducted.",
          "judgment": "Yes",
          "reasoning": "The use of wild-type and mutant controls satisfies the requirement for basic controls. Although the number of replicates is not explicitly stated, the experimental design implies repetition."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared wild-type LRRK2 to the Y1699C and G2019S mutants.",
          "judgment": "Yes",
          "reasoning": "The study used mutant controls (Y1699C and G2019S), fulfilling the requirement for variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Expression of the Y1699C mutant resulted in a loss of protection against oxidative stress compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The results show a functional difference between the Y1699C mutant and wild-type LRRK2. The mutant exhibited reduced tolerance to oxidative stress, indicating a loss of function."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Y1699C variant demonstrates a loss of function in protecting cells from oxidative stress, which is relevant to Parkinson's disease pathogenesis, supporting a pathogenic role. The evidence is considered supporting due to the lack of quantitative statistical analysis and limited number of variant controls."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutants of LRRK2 have been linked to the onset of parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The paper directly states a link between LRRK2 mutations and Parkinson's disease, establishing a disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study assessed tolerance to oxidative stress as a measure of LRRK2 function. Oxidative stress is implicated in Parkinson's disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay (oxidative stress tolerance) is relevant to the disease mechanism, as oxidative stress plays a role in Parkinson's disease, making the assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study used wild-type LRRK2 and mutant LRRK2 (Y1699C and G2019S) to assess tolerance to H2O2-induced oxidative stress in HEK293 and SH-SY5Y cells.",
          "judgment": "Yes",
          "reasoning": "The study included both wild-type and mutant controls, indicating basic controls were present. The experiment was performed using cell lines (HEK293 and SH-SY5Y)."
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type LRRK2 and mutant LRRK2 (Y1699C and G2019S) were used as controls. The study does not explicitly mention replicates but implies multiple experiments were conducted.",
          "judgment": "Yes",
          "reasoning": "The use of wild-type and mutant controls satisfies the requirement for basic controls. Although the number of replicates is not explicitly stated, the experimental design implies repetition."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared wild-type LRRK2 to the Y1699C and G2019S mutants.",
          "judgment": "Yes",
          "reasoning": "The study used mutant controls (Y1699C and G2019S), fulfilling the requirement for variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Expression of the G2019S mutant resulted in a loss of protection against oxidative stress compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The results show a functional difference between the G2019S mutant and wild-type LRRK2. The mutant exhibited reduced tolerance to oxidative stress, indicating a loss of function."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant demonstrates a loss of function in protecting cells from oxidative stress, which is relevant to Parkinson's disease pathogenesis, supporting a pathogenic role. The evidence is considered supporting due to the lack of quantitative statistical analysis and limited number of variant controls."
    }
  ]
}
```